1 |
1 |
MGH |
Erlotinib |
Tarceva, RG-1415, CP-358774, OSI-774, Ro-508231, R-1415 |
EGFR |
EGFR signaling |
2 |
3 |
MGH |
Rapamycin |
AY-22989, Sirolimus, WY-090217, Torisel, Rapamune |
MTORC1 |
PI3K/MTOR signaling |
3 |
5 |
MGH |
Sunitinib |
Sutent, Sunitinib Malate, SU-11248 |
PDGFR, KIT, VEGFR, FLT3, RET, CSF1R |
RTK signaling |
4 |
6 |
MGH |
PHA-665752 |
PHA665752, PHA 665752 |
MET |
RTK signaling |
5 |
9 |
MGH |
MG-132 |
LLL cpd, MG 132, MG132 |
Proteasome, CAPN1 |
Protein stability and degradation |
6 |
11 |
MGH |
Paclitaxel |
BMS-181339-01, Taxol, Onxol, Paxene, Praxel, Abraxane |
Microtubule stabiliser |
Mitosis |
7 |
17 |
MGH |
Cyclopamine |
|
SMO |
Other |
8 |
29 |
MGH |
AZ628 |
AZ-628, AZ 628 |
BRAF |
ERK MAPK signaling |
9 |
30 |
MGH |
Sorafenib |
Nexavar, 284461-73-0, BAY 43-9006 |
PDGFR, KIT, VEGFR, RAF |
RTK signaling |
10 |
32 |
MGH |
Tozasertib |
MK 0457,MK-0457,MK-045, VX-680 VX 680 VX-68 |
AURKA, AURKB, AURKC, others |
Mitosis |
11 |
34 |
MGH |
Imatinib |
Gleevec, STI-571 |
ABL, KIT, PDGFR |
Other, kinases |
12 |
35 |
MGH |
NVP-TAE684 |
NVP-TAE 684, TAE684, TAE-684 |
ALK |
RTK signaling |
13 |
37 |
MGH |
Crizotinib |
Xalkori, PF2341066, PF-2341066, PF 2341066 |
MET, ALK, ROS1 |
RTK signaling |
14 |
38 |
MGH |
Saracatinib |
AZD0530, AZD-0530, AZ-10353926 |
ABL, SRC |
Other, kinases |
15 |
41 |
MGH |
S-Trityl-L-cysteine |
NSC 83265, Tritylcysteine |
KIF11 |
Mitosis |
16 |
45 |
MGH |
Z-LLNle-CHO |
Z-L-Norleucine-CHO, Gamma-Secretase Inhibitor 1 |
gamma-secretase |
Other |
17 |
51 |
MGH |
Dasatinib |
BMS-354825-03, BMS-354825, Sprycel |
ABL, SRC, Ephrins, PDGFR, KIT |
RTK signaling |
18 |
52 |
MGH |
GNF-2 |
KIN001-013 |
BCR-ABL |
ABL signaling |
19 |
53 |
MGH |
CGP-60474 |
KIN001-019, CGP60474, CGP 60474 |
CDK1,CDK2,CDK5,CDK7,CDK9, PKC |
Cell cycle |
20 |
54 |
MGH |
CGP-082996 |
CINK4, KIN001-021 |
CDK4 |
Cell cycle |
21 |
55 |
MGH |
A-770041 |
KIN001-111 |
LCK, FYN |
Other, kinases |
22 |
56 |
MGH |
WH-4-023 |
KIN001-112 |
SRC, LCK |
Other, kinases |
23 |
59 |
MGH |
WZ-1-84 |
KIN001-123 |
BMX |
Other, kinases |
24 |
60 |
MGH |
BI-2536 |
|
PLK1, PLK2, PLK3 |
Cell cycle |
25 |
62 |
MGH |
BMS-536924 |
BMS 536924 |
IGF1R, IR |
IGF1R signaling |
26 |
63 |
MGH |
BMS-509744 |
KIN001-127, ITK inhibitor |
ITK |
Other, kinases |
27 |
64 |
MGH |
CMK |
KIN001-128 |
RSK2 |
Other, kinases |
28 |
71 |
MGH |
Pyrimethamine |
Daraprim, Chloridine |
Dihydrofolate reductase (DHFR) |
Other |
29 |
83 |
MGH |
JW-7-52-1 |
NA |
MTOR |
PI3K/MTOR signaling |
30 |
86 |
MGH |
A-443654 |
KIN001-139 |
AKT1, AKT2, AKT3 |
PI3K/MTOR signaling |
31 |
87 |
MGH |
GW843682X |
GW843682X (AN-13) |
PLK1 |
Cell cycle |
32 |
88 |
MGH |
Entinostat |
MS-275 |
HDAC1, HDAC3 |
Chromatin histone acetylation |
33 |
89 |
MGH |
Parthenolide |
|
HDAC1 |
Chromatin histone acetylation |
34 |
91 |
MGH |
GSK319347A |
KIN001-135, IKK-3 inhibitor |
IKK |
Other, kinases |
35 |
94 |
MGH |
TGX221 |
TGX-221, Tgx 221 |
PI3Kbeta |
PI3K/MTOR signaling |
36 |
104 |
MGH |
Bortezomib |
PS-341, LDP-341, Velcade |
Proteasome |
Protein stability and degradation |
37 |
106 |
MGH |
XMD8-85 |
ERK5-IN-1 |
ERK5, BET |
Other |
38 |
110 |
MGH |
Seliciclib |
Roscovitine, CYC-202, AL-39256 |
CDK2, CDK7, CDK9 |
Cell cycle |
39 |
111 |
MGH |
Salubrinal |
EIF-2alpha Inhibitor |
EIF2A |
Other |
40 |
119 |
MGH |
Lapatinib |
Tykerb, Tyverb |
EGFR, ERBB2 |
RTK signaling |
41 |
127 |
MGH |
GSK269962A |
GSK 269962A |
ROCK1, ROCK2 |
Cytoskeleton |
42 |
133 |
MGH |
Doxorubicin |
Doxil, Rubex, Adriamycin, Adriablastin, Doxorubicine |
Anthracycline |
DNA replication |
43 |
134 |
MGH |
Etoposide |
Etopophos, Vepesid, Eposin, VP-16 |
TOP2 |
DNA replication |
44 |
135 |
MGH |
Gemcitabine |
Gemzar, LY-188011 |
Pyrimidine antimetabolite |
DNA replication |
45 |
136 |
MGH |
Mitomycin-C |
Mytozytrex, NSC-26980, MMC, Mitosol, Mitozytrex |
DNA crosslinker |
DNA replication |
46 |
140 |
MGH |
Vinorelbine |
vinorelbine tartrate, Navelbine, Exelbine |
Microtubule destabiliser |
Mitosis |
47 |
147 |
MGH |
NSC-87877 |
NSC 87877 |
SHP-1 (PTPN6), SHP-2 (PTPN11) |
Other |
48 |
150 |
MGH |
Bicalutamide |
ICI-176334, Casodex, Cosudex, ICI 176334 |
AR |
Hormone-related |
49 |
151 |
MGH |
QS11 |
944328-88-5 |
ARFGAP1 |
Other |
50 |
152 |
MGH |
CP466722 |
CP-466722, CP 466722, 1080622-86-1 |
ATM |
Genome integrity |
51 |
153 |
MGH |
Midostaurin |
PKC412, benzoylstaurosporine, CGP-41251 |
PKC, PPK, FLT1, c-FGR, others |
Other |
52 |
154 |
MGH |
CHIR-99021 |
CT 99021, CHIR99021, CHIR 99021 |
GSK3A, GSK3B |
WNT signaling |
53 |
155 |
MGH |
Ponatinib |
AP24534, AP-24534, KIN001-192, Iclusig |
ABL, PDGFRA, VEGFR2, FGFR1, SRC, TIE2, FLT3 |
Other, kinases |
54 |
156 |
MGH |
AZD6482 |
AZD 6482, AZD-6482, AK-55409 |
PI3Kbeta |
PI3K/MTOR signaling |
55 |
157 |
MGH |
JNK-9L |
KIN001-204, JNK inhibitor 9l |
JNK2, JNK3 |
JNK and p38 signaling |
56 |
158 |
MGH |
PF-562271 |
PF-00562271 |
FAK, FAK2 |
Cytoskeleton |
57 |
159 |
MGH |
HG6-64-1 |
KIN001-206 |
BRAF |
ERK MAPK signaling |
58 |
163 |
MGH |
JQ1 |
JQ-1, (+)-JQ-1 |
BRD2, BRD3, BRD4, BRDT |
Chromatin other |
59 |
164 |
MGH |
JQ12 |
|
HDAC1, HDAC2 |
Chromatin histone acetylation |
60 |
165 |
MGH |
DMOG |
Dimethyloxalylglcine |
HIF-PH |
Metabolism |
61 |
166 |
MGH |
FTI-277 |
|
Farnesyl-transferase (FNTA) |
Other |
62 |
167 |
MGH |
OSU-03012 |
AR-12, OSU 03012, OSU03012, PDK1 inhibitor AR-12 |
PDK1 (PDPK1) |
Metabolism |
63 |
170 |
MGH |
Shikonin |
Anchusin |
not defined |
Other |
64 |
171 |
MGH |
AKT inhibitor VIII |
Akti-1/2, KIN001-102 |
AKT1, AKT2, AKT3 |
PI3K/MTOR signaling |
65 |
172 |
MGH |
Embelin |
Emberine, Embelic acid |
XIAP |
Apoptosis regulation |
66 |
173 |
MGH |
FH535 |
|
PPARgamma, PPARdelta |
Other |
67 |
175 |
MGH |
PAC-1 |
GTPL5238 |
Procaspase-3, Procaspase-7 |
Apoptosis regulation |
68 |
176 |
MGH |
IPA-3 |
IPA 3 |
PAK1 |
Cytoskeleton |
69 |
177 |
MGH |
GSK650394 |
GSK-650394, GSK 650394 |
SGK2, SGK3 |
Other, kinases |
70 |
178 |
MGH |
BAY-61-3606 |
Syk Inhibitor, BAY-613606 |
SYK |
Other, kinases |
71 |
179 |
MGH |
5-Fluorouracil |
5-FU |
Antimetabolite (DNA & RNA) |
Other |
72 |
180 |
MGH |
Thapsigargin |
Octanoic acid |
SERCA |
Other |
73 |
182 |
MGH |
Obatoclax Mesylate |
GX15-070MS, Obatoclax, GX15-070 |
BCL2, BCL-XL, BCL-W, MCL1 |
Apoptosis regulation |
74 |
184 |
MGH |
BMS-754807 |
BMS754807, BMS 754807 |
IGF1R, IR |
RTK signaling |
75 |
185 |
MGH |
Linsitinib |
OSI-906, ASP-7487 |
IGF1R |
IGF1R signaling |
76 |
186 |
MGH |
Bexarotene |
LG-100069, Targretin, Targret, Targrexin, Targretyn, Bexarotenum |
Retinioic X receptor (RXR) agonist |
Other |
77 |
190 |
MGH |
Bleomycin |
|
dsDNA break induction |
DNA replication |
78 |
192 |
MGH |
LFM-A13 |
DDE-28 |
BTK |
Other, kinases |
79 |
193 |
MGH |
GW-2580 |
GX2580, CFMS receptor tyrosine kinase inhibitor |
CSF1R |
RTK signaling |
80 |
194 |
MGH |
Luminespib |
AUY922, VER-52296,NVP-AUY922, AUY |
HSP90 |
Protein stability and degradation |
81 |
196 |
MGH |
Phenformin |
DBI |
Biguanide agent |
Other |
82 |
197 |
MGH |
Bryostatin 1 |
Bryostatin |
PKC |
Other |
83 |
199 |
MGH |
Pazopanib |
Votrient |
CSF1R, KIT, PDGFRA, PDGFRB |
RTK signaling |
84 |
200 |
MGH |
Dacinostat |
NVP-LAQ824, LAQ824 |
HDAC1 |
Chromatin histone acetylation |
85 |
201 |
MGH |
Epothilone B |
Patupilone, EpoB, EPO906, GNF-PF-193 |
Microtubule stabiliser |
Mitosis |
86 |
202 |
MGH |
GSK1904529A |
GSK-1904529A, GSK 1904529A |
IGF1R, IR |
RTK signaling |
87 |
203 |
MGH |
BMS-345541 |
BMS345541, IKK Inhibitor 3 |
IKK1, IKK2 |
Other, kinases |
88 |
204 |
MGH |
Tipifarnib |
Zarnestra |
Farnesyl-transferase (FNTA) |
Other |
89 |
205 |
MGH |
Avagacestat |
BMS-708163, BMS 708163 |
Amyloid beta20, Amyloid beta40 |
Other |
90 |
206 |
MGH |
Ruxolitinib |
INCB-18424, Ruxolitinib Phosphate, Jakafi |
JAK1, JAK2 |
Other, kinases |
91 |
207 |
MGH |
AS601245 |
|
JNK1, JNK2, JNK2 |
JNK and p38 signaling |
92 |
208 |
MGH |
Ispinesib Mesylate |
SB-715992 |
KSP |
Mitosis |
93 |
211 |
MGH |
TL-2-105 |
|
not defined |
Other |
94 |
219 |
MGH |
AT-7519 |
AT7519 |
CDK1, CDK2, CDK4, CDK6, CDK9 |
Cell cycle |
95 |
221 |
MGH |
TAK-715 |
KIN001-201, TAK 715 |
p38alpha, p38beta |
JNK and p38 signaling |
96 |
222 |
MGH |
BX-912 |
|
PDK1 (PDPK1) |
Metabolism |
97 |
223 |
MGH |
ZSTK474 |
KIN001-167, ZSTK-474, ZSTK 474 |
PI3K (class 1) |
PI3K/MTOR signaling |
98 |
224 |
MGH |
AS605240 |
KIN001-173, AS-605240 |
PI3Kgamma |
PI3K/MTOR signaling |
99 |
225 |
MGH |
Genentech Cpd 10 |
|
AURKA, AURKB |
Mitosis |
100 |
226 |
MGH |
GSK1070916 |
GSK-1070916 |
AURKA, AURKC |
Mitosis |